Article Details
Retrieved on: 2024-05-14 17:44:33
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a study on upadacitinib's efficacy in treating moderate to severe atopic dermatitis, showing early and sustained symptom improvement, which supports informed treatment decision-making in biotech relating to autoimmune diseases.
Article found on: www.dermatologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here